0001628280-23-006991.txt : 20230308 0001628280-23-006991.hdr.sgml : 20230308 20230308162124 ACCESSION NUMBER: 0001628280-23-006991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230307 FILED AS OF DATE: 20230308 DATE AS OF CHANGE: 20230308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koenig Sheldon L. CENTRAL INDEX KEY: 0001766524 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35986 FILM NUMBER: 23716381 MAIL ADDRESS: STREET 1: C/O PORTOLA PHARMACEUTICALS, INC. STREET 2: 270 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Esperion Therapeutics, Inc. CENTRAL INDEX KEY: 0001434868 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-887-3903 MAIL ADDRESS: STREET 1: 3891 RANCHERO DRIVE, SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: HDL THERAPEUTICS INC DATE OF NAME CHANGE: 20080513 4 1 wf-form4_167831047096030.xml FORM 4 X0306 4 2023-03-07 0 0001434868 Esperion Therapeutics, Inc. ESPR 0001766524 Koenig Sheldon L. C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 1 1 0 0 President and CEO Common Stock 2023-03-07 4 S 0 5441 5.056 D 194815 D Shares were sold to satisfy tax obligation on vested shares of performance-based restricted stock units. Consists of 194,815 shares of common stock held, including 1,999 shares recently acquired in Esperion's Employee Stock Purchase Plan. /s/ Sheldon L. Koenig 2023-03-08